Minimally Invasive Surgery: Using Natural Orifice Translumenal Endoscopic Surgery (NOTES)
| Status: | Recruiting |
|---|---|
| Conditions: | Other Indications, Gastrointestinal |
| Therapuetic Areas: | Gastroenterology, Other |
| Healthy: | No |
| Age Range: | 18 - 75 |
| Updated: | 5/3/2018 |
| Start Date: | February 2008 |
| End Date: | February 2020 |
| Contact: | Sarah Lazar, MPH |
| Email: | misresearch@ucsd.edu |
| Phone: | 619-471-0447 |
Natural Orifice Translumenal Endoscopic Surgery (NOTES): Laparoscopic Assisted Transgastric Appendectomy and Cholecystectomy
This is an observational study of pain and outcomes from patients undergoing transgastric
NOTES removal of their appendix or gallbladder. Subjects who elect to have a transgastric
NOTES removal of their appendix or gallbladder and agree to be in this study (through
signature on the informed consent form) will be followed per standard of care, with
additional follow-up for data collection including the following:
- Subjects will complete a 7 day pain/temperature log after surgery
- Subjects will receive a phone call at 6 months and at 1 year after surgery to capture
data related to safety, adverse events, hospitalizations and patient satisfaction
Additional data related to pain and outcomes will be collected at baseline/screening and at
follow-up as necessary.
NOTES removal of their appendix or gallbladder. Subjects who elect to have a transgastric
NOTES removal of their appendix or gallbladder and agree to be in this study (through
signature on the informed consent form) will be followed per standard of care, with
additional follow-up for data collection including the following:
- Subjects will complete a 7 day pain/temperature log after surgery
- Subjects will receive a phone call at 6 months and at 1 year after surgery to capture
data related to safety, adverse events, hospitalizations and patient satisfaction
Additional data related to pain and outcomes will be collected at baseline/screening and at
follow-up as necessary.
Inclusion criteria for the Group #1 transgastric appendectomy:
1. Males and Females between the ages of 18-75
2. Clinical diagnosis of appendicitis Emergency room evaluation within 36 hours of the
onset of pain
3. ASA classification I
4. Mentally competent to give informed consent.
5. Scheduled to undergo a transgastric NOTES appendectomy.
Exclusion criteria for group #1 transgastric appendectomy:
1. Pregnant women
2. Morbidly obese patients (Body mass index > 35)
3. Patients who are taking immunosuppressive medications or are immunocompromised
4. Patients who are on Proton Pump Inhibitors (PPI)
5. Patients with evidence of an abdominal abscess or mass on CT scan
6. Patients who present with a clinical diagnosis of sepsis
7. Patients who have a history of open abdominal surgery
8. Patients with diffuse peritonitis
9. Patients on blood thinners or aspirin
Inclusion criteria for Group #2 transgastric cholecystectomy:
1. Males and Females between the ages of 18 -75
2. Diagnosis of gallstone disease that require cholecystectomy
3. ASA classification I
4. Mentally competent to give informed consent.
5. Scheduled to undergo a transgastric NOTES cholecystectomy.
Exclusion criteria for Group #2 transgastric cholecystectomy:
1. Pregnant women
2. Patients with a Body mass index > 35
3. Patients who are taking immunosuppressive medications or are immunocompromised
4. Patients who are on Proton Pump Inhibitors (PPI)
5. Patients with suspicion of gallbladder cancer
6. Patients with a history of open abdominal surgery
7. Patients with known common bile duct stones (gallstones are not limited to the
gallbladder)
8. Patients on blood thinners or aspirin
We found this trial at
1
site
San Diego, California 92093
Principal Investigator: Santiago Horgan, MD
Click here to add this to my saved trials
